Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé & Laurent Bélec. (2020) Natural and vaccine-induced B cell-derived systemic and mucosal humoral immunity to human papillomavirus. Expert Review of Anti-infective Therapy 18:6, pages 579-607.
Read now
Read now
Edith MG van Esch, Marij JP Welters, Ekaterina S Jordanova, J Baptist MZ Trimbos, Sjoerd H van der Burg & Mariëtte IE van Poelgeest. (2012) Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy. Expert Review of Vaccines 11:7, pages 821-840.
Read now
Read now
Articles from other publishers (16)
Samantha Morais, Michel D Wissing, Farzin Khosrow-Khavar, Ann N Burchell, Pierre-Paul Tellier, François Coutlée, Tim Waterboer, Mariam El-Zein & Eduardo L Franco. (2023) Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study. The Journal of Infectious Diseases 227:10, pages 1173-1184.
Crossref
Crossref
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Camélia Gubavu, Thierry Prazuck, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé & Laurent Bélec. (2020) Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. PLOS ONE 15:5, pages e0233084.
Crossref
Crossref
Dominique Rosillon, Laurence Baril, Maria Rowena Del Rosario‐Raymundo, Cosette Marie Wheeler, Susan Rachel Skinner, Suzanne Marie Garland, Jorge Salmeron, Eduardo Lazcano‐Ponce, Carlos Santiago Vallejos, Tanya Stoney, Bram ter Harmsel, Timothy Yong Kuei Lim, Swee Chong Quek, Galina Minkina, Shelly Ann McNeil, Celine Bouchard, Kah Leng Fong, Deborah Money, Arunachalam Ilancheran, Alevtina Savicheva, Margaret Cruickshank, Archana Chatterjee, Alison Fiander, Mark Martens, Marie Cecile Bozonnat, Frank Struyf, Gary Dubin & Xavier Castellsagué. (2019) Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies. Cancer Medicine 8:10, pages 4938-4953.
Crossref
Crossref
Daniel C. Beachler, Raphael Viscidi, Elizabeth A. Sugar, Howard Minkoff, Howard D. Strickler, Ross D. Cranston, Dorothy J. Wiley, Lisa P. Jacobson, Kathleen M. Weber, Joseph B. Margolick, Susheel Reddy, Maura L. Gillison & Gypsyamber D’Souza. (2015) A Longitudinal Study of Human Papillomavirus 16 L1, E6, and E7 Seropositivity and Oral Human Papillomavirus 16 Infection. Sexually Transmitted Diseases 42:2, pages 93-97.
Crossref
Crossref
Xavier Castellsagué, Paulo Naud, Song-Nan Chow, Cosette M. Wheeler, Maria Julieta V. Germar, Matti Lehtinen, Jorma Paavonen, Unnop Jaisamrarn, Suzanne M. Garland, Jorge Salmerón, Dan Apter, Henry Kitchener, Julio C. Teixeira, S. Rachel Skinner, Genara Limson, Anne Szarewski, Barbara Romanowski, Fred Y. Aoki, Tino F. Schwarz, Willy A. J. Poppe, F. Xavier Bosch, Newton S. de Carvalho, Klaus Peters, Wiebren A. A. Tjalma, Mahboobeh Safaeian, Alice Raillard, Dominique Descamps, Frank Struyf, Gary Dubin, Dominique Rosillon & Laurence Baril. (2014) Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA. The Journal of Infectious Diseases 210:4, pages 517-534.
Crossref
Crossref
Mirte Scherpenisse, Rutger M. Schepp, Madelief Mollers, Chris J. L. M. Meijer, Guy A. M. Berbers & Fiona R. M. van der Klis. (2013) Characteristics of HPV-Specific Antibody Responses Induced by Infection and Vaccination: Cross-Reactivity, Neutralizing Activity, Avidity and IgG Subclasses. PLoS ONE 8:9, pages e74797.
Crossref
Crossref
Matti Lehtinen & Joakim Dillner. (2013) Clinical trials of human papillomavirus vaccines and beyond. Nature Reviews Clinical Oncology 10:7, pages 400-410.
Crossref
Crossref
Margarita Pons-Salort, Véronique Letort, Michel Favre, Isabelle Heard, Benoit Dervaux, Lulla Opatowski & Didier Guillemot. (2013) Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: A model-based approach. Vaccine 31:8, pages 1238-1245.
Crossref
Crossref
Matti Lehtinen, Pekka Nieminen, Dan Apter, Proscowa Namujju, Kari Natunen, Mohsin Rana & Jorma Paavonen. 2012. HPV and Cervical Cancer. HPV and Cervical Cancer
257
272
.
Proscovia B Namujju, Lea Hedman, Klaus Hedman, Cecily Banura, Edward K Mbidde, Dennison Kizito, Romano N Byaruhanga, Moses Muwanga, Reinhard Kirnbauer, Heljä-Marja Surcel & Matti Lehtinen. (2011) Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence. BMC Research Notes 4:1.
Crossref
Crossref
Alberto Monroy-García, Miguel A Gómez-Lim, Benny Weiss-Steider, Georgina Paz-de la Rosa, Jorge Hernández-Montes, Karyna Pérez-Saldaña, Yessica S Tapia-Guerrero, Mariel E Toledo-Guzmán, Edelmiro Santiago-Osorio, Héctor I Sanchez-Peña & María deLourdes Mora-García. (2011) A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection. Virology Journal 8:1.
Crossref
Crossref
P. B. Namujju, T. Waterboer, C. Banura, R. Muwonge, E. K. Mbidde, R. Byaruhanga, M. Muwanga, H.-M. Surcel, M. Pawlita & M. Lehtinen. (2011) Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women. Journal of General Virology 92:12, pages 2776-2783.
Crossref
Crossref
Sadeep Shrestha. (2011) Influence of host genetic and ecological factors in complex concomitant infections – relevance to sexually transmitted infections. Journal of Reproductive Immunology 92:1-2, pages 27-32.
Crossref
Crossref
Ian H. FrazerGraham R. LeggattStephen R. Mattarollo. (2011) Prevention and Treatment of Papillomavirus-Related Cancers Through Immunization. Annual Review of Immunology 29:1, pages 111-138.
Crossref
Crossref
Marko Merikukka, Marjo Kaasila, Proscovia B. Namujju, Johanna Palmroth, Reinhard Kirnbauer, Jorma Paavonen, Heljä‐Marja Surcel & Matti Lehtinen. (2010) Differences in incidence and co‐occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. International Journal of Cancer 128:5, pages 1114-1119.
Crossref
Crossref
Kari Natunen, Johannes Lehtinen, Proscovia Namujju, John Sellors & Matti Lehtinen. (2011) Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Infectious Diseases in Obstetrics and Gynecology 2011, pages 1-10.
Crossref
Crossref